These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20083869)

  • 1. Primary central nervous system lymphoma: prognostication as per international extranodal lymphoma study group score and reactive CD3 collar.
    Kumari N; Krishnani N; Rawat A; Agarwal V; Lal P
    J Postgrad Med; 2009; 55(4):247-51. PubMed ID: 20083869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary central nervous system lymphoma: a profile of 26 cases from Western India.
    Agarwal PA; Menon S; Smruti BK; Singhal BS
    Neurol India; 2009; 57(6):756-63. PubMed ID: 20139505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of the aggregative perivascular growth pattern of tumor cells in primary central nervous system diffuse large B-cell lymphoma.
    He M; Zuo C; Wang J; Liu J; Jiao B; Zheng J; Cai Z
    Neuro Oncol; 2013 Jun; 15(6):727-34. PubMed ID: 23482670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined tumor-associated macrophages biomarker predicting extremely poor outcome of patients with primary central nervous system lymphoma.
    Sun X; Wang C; Chen C; Huang J; Wu X; Wang Y; He X; Cao J; Jiang W; Sun P; Li Z
    Hematol Oncol; 2021 Dec; 39(5):625-638. PubMed ID: 34543472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.
    Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC
    Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the IELSG 14 study).
    Messina C; Ferreri AJ; Govi S; Bruno-Ventre M; Gracia Medina EA; Porter D; Radford J; Heo DS; Park HY; Pro B; Jayamohan J; Visco C; Scarfò L; Zucca E; Gospodarowicz M; Christie D;
    Br J Haematol; 2014 Mar; 164(6):834-40. PubMed ID: 24383942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma.
    Imai H; Shimada K; Shimada S; Abe M; Okamoto M; Kitamura K; Kinoshita T; Shiraishi T; Nakamura S
    Pathol Int; 2009 Jul; 59(7):431-7. PubMed ID: 19563405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of POD18 combined with improved IELSG in primary central nervous system lymphoma.
    Du KX; Shen HR; Pan BH; Luthuli S; Wang L; Liang JH; Li Y; Yin H; Li JY; Wu JZ; Xu W
    Clin Transl Oncol; 2024 Mar; 26(3):720-731. PubMed ID: 37558851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial.
    Vitolo U; Chiappella A; Ferreri AJ; Martelli M; Baldi I; Balzarotti M; Bottelli C; Conconi A; Gomez H; Lopez-Guillermo A; Martinelli G; Merli F; Novero D; Orsucci L; Pavone V; Ricardi U; Storti S; Gospodarowicz MK; Cavalli F; Sarris AH; Zucca E
    J Clin Oncol; 2011 Jul; 29(20):2766-72. PubMed ID: 21646602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomas.
    Ponzoni M; Berger F; Chassagne-Clement C; Tinguely M; Jouvet A; Ferreri AJ; Dell'Oro S; Terreni MR; Doglioni C; Weis J; Cerati M; Milani M; Iuzzolino P; Motta T; Carbone A; Pedrinis E; Sanchez J; Blay JY; Reni M; Conconi A; Bertoni F; Zucca E; Cavalli F; Borisch B;
    Br J Haematol; 2007 Aug; 138(3):316-23. PubMed ID: 17555470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Memorial Sloan-Kettering Cancer Center and International Extranodal Lymphoma Study Group prognostic scoring systems to predict Overall Survival in intracranial Primary CNS lymphoma.
    Jahr G; Broi MD; Holte H; Beiske K; Meling TR
    Brain Behav; 2018 Mar; 8(3):e00928. PubMed ID: 29541540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological features of primary diffuse large B-cell lymphoma of the central nervous system - strong EZH2 expression implying diagnostic and therapeutic implication.
    Guo S; Bai Q; Rohr J; Wang Y; Liu Y; Zeng K; Yu K; Zhang X; Wang Z
    APMIS; 2016 Dec; 124(12):1054-1062. PubMed ID: 27807891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic features of B-Cell lineage neoplasms with aberrant expression of CD3: a study of 21 cases.
    Oliveira JL; Grogg KL; Macon WR; Dogan A; Feldman AL
    Am J Surg Pathol; 2012 Sep; 36(9):1364-70. PubMed ID: 22895269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system involvement in diffuse large B-cell lymphoma.
    Yamamoto W; Tomita N; Watanabe R; Hattori Y; Nakajima Y; Hyo R; Hashimoto C; Motomura S; Ishigatsubo Y
    Eur J Haematol; 2010 Jul; 85(1):6-10. PubMed ID: 20236301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of time-dependent prognostic factors predicting early death but not long-term outcome in primary CNS lymphoma: a study of 91 patients.
    Ghesquières H; Drouet Y; Sunyach MP; Sebban C; Chassagne-Clement C; Jouanneau E; Honnorat J; Biron P; Blay JY
    Hematol Oncol; 2013 Jun; 31(2):57-64. PubMed ID: 22886543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse large B-cell lymphoma involving the central nervous system.
    Gualco G; Weiss LM; Barber GN; Bacchi CE
    Int J Surg Pathol; 2011 Feb; 19(1):44-50. PubMed ID: 21087986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in primary central nervous system lymphomas.
    Ferreri AJ; Reni M
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):629-49, vi. PubMed ID: 16083827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SHP-1 expression in primary central nervous system B-cell lymphomas in immunocompetent patients reflects maturation stage of normal B cell counterparts.
    Sugita Y; Tokunaga O; Nakashima A; Shigemori M
    Pathol Int; 2004 Sep; 54(9):659-66. PubMed ID: 15363033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary central nervous system lymphoma: a study of clinicopathological features and trend in western India.
    Pasricha S; Gupta A; Gawande J; Trivedi P; Patel D
    Indian J Cancer; 2011; 48(2):199-203. PubMed ID: 21768666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.